EMD-29713

Single-particle
3.02 Å
EMD-29713 Deposition: 08/02/2023
Map released: 09/08/2023
Last modified: 27/09/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-29713

KRAS G12C complex with GDP imaged on a cryo-EM imaging scaffold

EMD-29713

Single-particle
3.02 Å
EMD-29713 Deposition: 08/02/2023
Map released: 09/08/2023
Last modified: 27/09/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: synthetic construct, Homo sapiens
Sample: KRAS G12C displayed on a Cryo-EM imaging scaffold
Fitted models: 8g42 (Avg. Q-score: 0.504)

Deposition Authors: Castells-Graells R , Sawaya MR , Yeates TO
Cryo-EM structure determination of small therapeutic protein targets at 3 angstrom -resolution using a rigid imaging scaffold.
PUBMED: 37669364
DOI: doi:10.1073/pnas.2305494120
ISSN: 1091-6490
ASTM: PNASA6
Abstract:
Cryoelectron microscopy (Cryo-EM) has enabled structural determination of proteins larger than about 50 kDa, including many intractable by any other method, but it has largely failed for smaller proteins. Here, we obtain structures of small proteins by binding them to a rigid molecular scaffold based on a designed protein cage, revealing atomic details at resolutions reaching 2.9 Å. We apply this system to the key cancer signaling protein KRAS (19 kDa in size), obtaining four structures of oncogenic mutational variants by cryo-EM. Importantly, a structure for the key G12C mutant bound to an inhibitor drug (AMG510) reveals significant conformational differences compared to prior data in the crystalline state. The findings highlight the promise of cryo-EM scaffolds for advancing the design of drug molecules against small therapeutic protein targets in cancer and other human diseases.